Volker Witt

Summary

Affiliation: St. Anna Children's Hospital
Country: Austria

Publications

  1. ncbi Performance of a new separator system for routine autologous hematopoietic progenitor cell collection in small children
    Volker Witt
    St Anna Kinderspital, Vienna, Austria
    J Clin Apher 22:306-13. 2007
  2. ncbi Training courses for pediatric apheresis on site; how apheresis technology transfer can be performed
    Volker Witt
    St Anna Kinderspital, Kinderspitalgasse 6, 1090 Vienna, Austria
    Transfus Apher Sci 43:223-5. 2010
  3. ncbi World apheresis registry data from 2003 to 2007, the pediatric and adolescent side of the registry
    Volker Witt
    St Anna Kinderspital, Vienna, Austria
    Transfus Apher Sci 39:255-60. 2008
  4. ncbi Bone marrow processing with the AMICUS™ separator system
    V Witt
    St Anna Kinderspital, Vienna, Austria
    J Clin Apher 26:195-9. 2011
  5. ncbi Robust multi-parameter single-platform quantification of myeloid and B-lymphoid CD34 progenitor cells in all clinical CD34 cell sources and in thawed PBSC
    Gerhard Fritsch
    Children s Cancer Research Institute, Vienna, Austria
    Pediatr Hematol Oncol 29:595-610. 2012
  6. ncbi Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experienc
    Nina Worel
    Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria
    Transfusion 51:968-75. 2011
  7. ncbi Comparative evaluation of techniques for the manufacturing of dendritic cell-based cancer vaccines
    Alexander Michael Dohnal
    Laboratory of Tumour Immunology, St Anna Children s Cancer Research Institute, Vienna, Austria
    J Cell Mol Med 13:125-35. 2009
  8. ncbi Novel single-platform multiparameter FCM analysis of apoptosis: Significant differences between wash and no-wash procedure
    Julia Stemberger
    Children s Cancer Research Institute, St Anna Kinderkrebsforschung, Vienna, Austria
    Cytometry A 77:1075-81. 2010
  9. ncbi Granulocyte transfusions in children and young adults: does the dose matter?
    Markus G Seidel
    St Anna Children s Hospital, Vienna, Austria
    J Pediatr Hematol Oncol 31:166-72. 2009

Collaborators

Detail Information

Publications9

  1. ncbi Performance of a new separator system for routine autologous hematopoietic progenitor cell collection in small children
    Volker Witt
    St Anna Kinderspital, Vienna, Austria
    J Clin Apher 22:306-13. 2007
    ..With the AMICUS we saw statistically less citrate reactions compared to the CS 3000. We conclude that the AMICUS system is safe and efficient to harvest PBSC on a routine basis in pediatric patients, even in children < or =10 kg bw...
  2. ncbi Training courses for pediatric apheresis on site; how apheresis technology transfer can be performed
    Volker Witt
    St Anna Kinderspital, Kinderspitalgasse 6, 1090 Vienna, Austria
    Transfus Apher Sci 43:223-5. 2010
    ..In the future this could be a way for quality control in pediatric apheresis...
  3. ncbi World apheresis registry data from 2003 to 2007, the pediatric and adolescent side of the registry
    Volker Witt
    St Anna Kinderspital, Vienna, Austria
    Transfus Apher Sci 39:255-60. 2008
    ..In order to provide more information of apheresis practise in children and young adults (<21a) we will report of knowledge learnt by data from the registry from 2003 until 2007...
  4. ncbi Bone marrow processing with the AMICUS™ separator system
    V Witt
    St Anna Kinderspital, Vienna, Austria
    J Clin Apher 26:195-9. 2011
    ..To evaluate the performance of the MNC collection program of the Amicus device for BM, we analysed our data obtained from the Amicus and the Fenwal CS3000omnix™ plus device...
  5. ncbi Robust multi-parameter single-platform quantification of myeloid and B-lymphoid CD34 progenitor cells in all clinical CD34 cell sources and in thawed PBSC
    Gerhard Fritsch
    Children s Cancer Research Institute, Vienna, Austria
    Pediatr Hematol Oncol 29:595-610. 2012
    ....
  6. ncbi Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experienc
    Nina Worel
    Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria
    Transfusion 51:968-75. 2011
    ..In this named patient program we report the Austrian experience in insufficiently mobilizing patients...
  7. ncbi Comparative evaluation of techniques for the manufacturing of dendritic cell-based cancer vaccines
    Alexander Michael Dohnal
    Laboratory of Tumour Immunology, St Anna Children s Cancer Research Institute, Vienna, Austria
    J Cell Mol Med 13:125-35. 2009
    ..4 +/- 6.4 ng/ml). We conclude that significant steps were taken here towards clinical grade DC cancer vaccine manufacturing...
  8. ncbi Novel single-platform multiparameter FCM analysis of apoptosis: Significant differences between wash and no-wash procedure
    Julia Stemberger
    Children s Cancer Research Institute, St Anna Kinderkrebsforschung, Vienna, Austria
    Cytometry A 77:1075-81. 2010
    ..We conclude that the described test is a feasible and reliable tool for apoptosis measurement and it provides results that are definitely closer to the truth than those obtained from kits that require cell washing...
  9. ncbi Granulocyte transfusions in children and young adults: does the dose matter?
    Markus G Seidel
    St Anna Children s Hospital, Vienna, Austria
    J Pediatr Hematol Oncol 31:166-72. 2009
    ..Granulocyte transfusions (GTs) may increase the absolute neutrophil count (ANC) before hematopoietic regeneration in neutropenic patients after chemotherapy or hematopoietic stem cell transplantation and support anti-infective immunity...